# OnCo record beatcc (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/beatcc/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "beatcc", "NCT03556839" ;
  schema:name "BEATcc / ENGOT-Cx10 / GOG-3030"@en ;
  schema:description "A second immunotherapy confirmed that adding a checkpoint inhibitor to chemotherapy plus bevacizumab extends life in advanced cervical cancer."@en ;
  schema:url <https://onco.cc/trials/beatcc/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03556839>, <https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02517-3/fulltext> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2018-09-25" ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/recurrent-metastatic-cervical-cancer/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pdl1/>, <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/paclitaxel/> ;
  onco:companies <https://onco.cc/companies/roche-genentech/> ;
  onco:people <https://onco.cc/people/antonio-gonzalez-martin/> .